Is the Time Ripe to Buy Johnson & Johnson (JNJ) Stock?
If you owned Johnson & Johnson (NYSE:JNJ) stock at the beginning of 2013, you're sitting atop gains of more than 20% right now.
Posts Tagged ‘Johnson & Johnson (JNJ)’
Johnson & Johnson (JNJ), NIKE, Inc. (NKE): Prediction of a Future Stock Split
This article will present the next company that I see poised to split its shares two for one.
The Coca-Cola Company (KO), Johnson & Johnson (JNJ): Does Europe Really Affect the Dow Jones Industrial Average (.DJI)?
When it comes to early-morning market predictions, U.S. investors often turn to overseas markets as a guide for how U.S. stocks will fare.
Sanofi SA (ADR) (SNY), Novo Nordisk A/S (ADR) (NVO), Johnson & Johnson (JNJ): Can Investors Bet on These 3 Pharma Companies?
It is expected that the death rate from diabetes will top 50% in the next ten years, which will make it a leading cause of death worldwide.
Will Pfizer Inc. (PFE) Stock Soar or Sink for the Rest of 2013?
Pfizer Inc. (NYSE:PFE) stock is off to a fine start in 2013.
Johnson & Johnson (JNJ), The Clorox Co (CLX), The Procter & Gamble Company (PG): Three Companies for the Long Haul
Bonds are not the only viable option for income investors. Today’s low interest rates being paid on government bonds makes dividend-paying stocks a more savvy choice.
Idenix Pharmaceuticals Inc (IDIX), Bristol Myers Squibb Co. (BMY): The Most Unlucky Biotech in the World
Idenix Pharmaceuticals Inc (NASDAQ:IDIX) just can't catch a break.
Johnson & Johnson (JNJ), Sanofi SA (ADR) (SNY): Health Care Investment Ideas From Warren Buffett
Famed investor Warren Buffett once called the high cost of health care a "tapeworm eating at our economic body." While he might be disgusted by the costs, it hasn't stopped ...
Johnson & Johnson (JNJ), UnitedHealth Group Inc. (UNH): These Stocks Are Defying the Dow Jones Industrial Average (.DJI)’s Drop
The Dow Jones Industrial Average (INDEXDJX:.DJI) is down 155 points, or 1.05%, as of 1:15 p.m. EDT as the sell-off in the U.S.
D.R. Horton, Inc. (DHI), Lennar Corporation (LEN): Why Stocks Are Shooting Higher
Blue-chip stocks are surging this afternoon following a number of better-than-expected economic reports related to jobs, income, spending, inflation, and home sales.
Microsoft Corporation (MSFT), Google Inc (GOOG): Socially Responsible Investing the Easy Way
Exchange-traded funds and socially responsible investing (SRI) have each grown in popularity over the past two decades or so; ETFs for their convenience and SRI to achieve great...
VIVUS, Inc. (VVUS), ISIS Pharmaceuticals, Inc. (ISIS), Gilead Sciences, Inc. (GILD): Biotech Companies Battle It Out
Biotech companies sometimes get lucky, launching a drug into a new indication where there's no competition, but more often than not the biotech companies have to battle it out...
Is This What the Doctor Ordered for Eli Lilly & Co. (LLY)?
After the failure of its pipeline products for Alzheimer’s and rheumatoid arthritis, the drug giant Eli Lilly & Co. (NYSE:LLY) finally has some good news to report.
Oncolytics Biotech, Inc. (USA) (ONCY): This High-Risk, High-Reward Biotech Is Worth a Look
Let me preface this by saying that investing in the biotech sector can sometimes be nothing more than speculating.
Johnson & Johnson (JNJ), United States Steel Corporation (X): One Simple Trick to Boost Your Returns
From highly-innovative companies like Apple to cyclical companies like U.S.
Johnson & Johnson (JNJ): New Drugs and Better Manufacturing Make This Stock a Buy
Johnson & Johnson (NYSE:JNJ) stands alone as a leader across the major health-care industries.
Gilead Sciences, Inc. (GILD): This Biotech Leader Is Poised to Outperform
Investing in biotech companies can be risky; developing new drugs is a long, expensive, and uncertain process, and there is always considerable regulatory risk in the industry...
Buy Johnson & Johnson (JNJ)?
Stocks that stand the test of time are often ones that have a diversified product portfolio of world class brands.
Abbott Laboratories (ABT), AbbVie Inc (ABBV): This Healthcare Giant is Definitely a Great Buy Now
I am always excited when a company plans to return more cash to its shareholders in both dividends and share buybacks.
Raynor: What Makes Merck & Co., Inc. (MRK) an Exceptional Company
A director at Deloitte Services LP and co-author of The Three Rules: How Exceptional Companies Think, Michael Raynor joins The Fool to share his findings about what makes a company...
Johnson & Johnson (JNJ): Why Might This Play Shake Up the Cancer-Drug Industry?
Medical firm Johnson & Johnson (NYSE:JNJ) recently announced a private-company acquisition that could have major implications for one of the markets in which it operates.
Hedge Fund News: Ray Dalio, Yahoo! Inc. (YHOO), Goldman Sachs Group, Inc. (GS)
Editor's Note: Related tickers: Yahoo! Inc. (NASDAQ:YHOO), Bank of America Corp (NYSE:BAC), Goldman Sachs Group, Inc.
Hedge Funds Are Betting On Pfizer Inc. (PFE)
Pfizer Inc. (NYSE:PFE) was in 81 hedge funds' portfolio at the end of the first quarter of 2013. PFE shareholders have witnessed an increase in hedge fund interest recently.
If Only Johnson & Johnson (JNJ) Could Bottle This and Sell It
I was just a kid in 1982 when Johnson & Johnson (NYSE:JNJ) was forced to recall its Tylenol capsules, but I remember it like it was yesterday.
Is Now a Great Time to Buy Abbott Laboratories (ABT)?
There's no question that Abbott Laboratories (NYSE:ABT) started 2013 with a bang. The year began with the spinoff of AbbVie Inc (NYSE:ABBV).
Medivation Inc (MDVN), Onyx Pharmaceuticals, Inc. (ONXX): Biotechs Take a Dive After a Standout Start to 2013
Are investors hitting the brakes on biotech? The biotech sector's one of the most boom-or-bust areas for investors, where fortunes can be won or lost.
Baxter International Inc. (BAX) Healthcare Stock Checkup
There is plenty of good news to support the 30% move made by Baxter International Inc. (NYSE:BAX) shares in the past year.
Johnson & Johnson (JNJ), PepsiCo, Inc. (PEP): Why You Should Embrace Falling Markets
It’s a scary investing world out there.
Billionaire Stanley Druckenmiller’s 3% Yield and Higher Picks Include Pfizer Inc. (PFE)
In May, billionaire Stanley Druckenmiller- the former manager of Duquesne Capital, though he may be better known as one of George Soros’s portfolio managers- filed his 13F for...
Intel Corporation (INTC), AT&T Inc. (T): Should Long-Term Investors Go for Dividends or Blue-Chip Bonds?
Given the recent boost in bond yields, let's compare dividend yields to bond yields for the 30 companies in the Dow Jones Industrial Average .
B&G Foods, Inc. (BGS), Johnson & Johnson (JNJ): Three Growing Companies Building Powerful Brands
B&G Foods, Inc. (NYSE:BGS) just announced plans to buy Robert's American Gourmet Food, best known for its Pirates Booty brand.
Allergan, Inc. (AGN), GlaxoSmithKline plc (ADR) (GSK): The Top 3 Medical Uses of Botox
Botox may be best known for its ability to combat crow's feet and other facial wrinkles, but it also serves an important role in the medical community.
CVS Caremark Corporation (CVS), Johnson and Johnson (JNJ): Should You Buy Stocks Discarded By Warren Buffett?
You may know the phrase "..... our favorite holding period is forever," part of a famous line uttered by mega-billionaire investor and philanthropist Warren Buffett.
The Procter & Gamble Company (PG), Colgate-Palmolive Company (CL): Old CEO, New Prospects
There have been numerous successful turnarounds for companies after their old CEO’s have been hired back.
Onyx Pharmaceuticals, Inc. (ONXX), Arena Pharmaceuticals, Inc. (ARNA): The Top 5 Diseases Caused by Obesity
In the "Global Burden of Disease" report from the World Health Organization, which was compiled over a 20-year period from 1990 through 2010 using data from 500 researchers from...
Intuitive Surgical, Inc. (ISRG), MAKO Surgical Corp. (MAKO): This Is the Leading Cause of Preventable Hospital Patient Deaths
When we go to the hospital, the last thing on our mind is that something could go wrong or that we could actually become sicker than when we first went in.
Eli Lilly & Co. (LLY), Merck & Co., Inc. (MRK): Another Alzheimer’s Disease Failure
The latest drug to bite the dust is LY2886721, a beta secretase, or BACE, inhibitor.
Johnson & Johnson (JNJ): Is This Healthcare Company a Strong Investment?
The slowdown in stock market has also adversely affected leading healthcare companies’ stocks.
Undervalued Teva Pharmaceutical Industries Ltd (ADR) (TEVA) Must Enter New Markets
Generic producers are often regarded as the safer players within BioPharma.
Two More Good Reasons to Buy Celgene Corporation (CELG)
Celgene Corporation (NASDAQ:CELG) shares have soared more than 46% so far in 2013.
The Cooper Companies, Inc. (COO), Valeant Pharmaceuticals Intl Inc (VRX): Tme to Buy This Defensive Growth Stock?
Everyone loves a defensive growth story, and there aren’t many better companies in the category than The Cooper Companies, Inc. (NYSE:COO).
Johnson & Johnson (JNJ), Vertex Pharmaceuticals Incorporated (VRTX): Inside HCV, An Interview with Janssen
Our job here is to examine companies through an investing perspective.
Johnson & Johnson (JNJ), The Coca-Cola Company (KO), AT&T Inc. (T): Three High Dividend Stocks to Consider at Market Dips
Wall Street fell recently as high-yielding dividend stocks lost their traction.
Facebook Inc (FB), Yahoo! Inc. (YHOO), Microsoft Corporation (MSFT): Five Companies That Buy Their Innovation
The tech sector is its own animal. And to remain relevant, companies like Facebook Inc (NASDAQ:FB) spend billions of dollars buying start-ups.
Johnson & Johnson (JNJ), VIVUS, Inc. (VVUS): The Three Biggest Risk Factors for a Stroke
Often referred to as "the silent killer," stroke is the fourth-leading cause of the death in the U.S., behind only heart disease, cancer, and chronic lower respiratory diseases...
GlaxoSmithKline plc (ADR) (GSK), Merck & Co., Inc. (MRK): Why You Should Care About This Diabetes Drug Saga
GlaxoSmithKline plc (ADR) (NYSE:GSK)'s diabetes drug Avandia causes heart issues. Or maybe it doesn't.
AFLAC Incorporated (AFL), Johnson & Johnson (JNJ): To Protect Yourself Against Falling Markets, Consider Dollar Cost Averaging
Investors are always looking for new strategies to beat the market over time and build wealth to ensure their financial futures.
Take Your Pick: The Procter & Gamble Company (PG) vs Johnson & Johnson (JNJ)
You can practice the same rule (although that is no guarantee that you will achieve the success of Buffett), and a good place to start is investing in the companies that make ...
